Game Changing Neoadjuvant Lung Trial Enrolls the Most People in the World
March 16, 2022 – Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”
Neoadjuvant Opdivo (nivolumab) plus chemotherapy significantly improves event-free survival in patients with resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial. The trial adds immunotherapy and chemotherapy for nine weeks before lung surgery. “The patients who had immunotherapy, when they went to surgery, 24% or nearly 1 in 4, the cancer was all gone. When you just gave chemotherapy for that same duration, in only 2% of the patients was the cancer gone. So, it’s just a game-changer,” Saylors said.
This protocol, called Checkmate 816, delivered significantly better outcomes than patients going straight to surgery. Per Bristol Myers Squibb’s November 2021 published findings, CheckMate -816 is the first Phase 3 trial with an immunotherapy-based combination to demonstrate improved event-free survival and pathologic complete response in the neoadjuvant setting of non-small cell lung cancer.
Positive results reinforce the improved efficacy of Opdivo-based treatments in four Phase 3 clinical trials in earlier-stage cancers, including lung cancer, bladder cancer, esophageal/gastroesophageal junction cancer, and melanoma.
Charleston Oncology provides the largest number of oncology and hematology clinical trials in the greater Charleston area. Located in West Ashley, North Charleston, Mount Pleasant, Downtown Peninsula Charleston, Summerville, and Walterboro, Charleston Oncology is a full-service oncology and hematology practice with eleven physicians. To schedule an appointment or learn more, visit www.CharlestonOncology.com.
Send UsA Message
The Power of a United Breast Cancer Team: Your Leading Breast Cancer Allies
From diagnosis to treatment and follow-ups, Charleston Oncology, as a part of the Department of Bon Secours St. Francis’ leading multidisciplinary cancer care team, plays a vital role in guiding patients through their breast cancer journey.
Celebrating Strength and Hope: Join Us for the 6th Annual Pink Promenade
Celebrating Strength and Hope: Join Us for the 6th Annual Pink Promenade Mount Pleasant Towne Centre is thrilled to announce our 6th Annual Pink Promenade Breast Cancer Awareness Fundraiser, an event that embodies hope, strength, and resilience. Scheduled for...
Jenny’s Journey Reflects Our Mission
At Charleston Oncology, the mission of healing all people with compassion, faith and excellence resonates through the hallways and translates into every patient interaction.
Myra Walks in a Patient’s Shoes
In the busy corridors of Charleston Oncology on a triple-booked day of patients, a moment of pure human kindness unfolded, illustrating what it truly means to walk in a patient’s shoes.
March is National Colorectal Cancer Awareness Month
March is Colorectal Cancer Awareness Month. This month, Charleston Oncology recognizes the importance of spreading awareness surrounding the disease.
Empowering Health: Charleston Oncology Observes National Cancer Prevention Month
Empowering Health: Charleston Oncology Observes National Cancer Prevention Month Every year in the United States, nearly 1.9 million people (about twice the population of South Dakota) face the life-altering diagnosis of cancer, according to the National Institutes of...